CAS: 67443-38-3; 5-Bromo-2-Chloro-3-Nitropyridine

相似化合物

588729-99-1 856850-68-5 186413-75-2

上下游产品

CAS号6945-68-2 2-氨基-5-溴-3-硝基吡啶 | CAS号15862-34-7 5-溴-2-羟基-3-硝基吡啶 | CAS号68-12-2 N,N-二甲基甲酰胺 | CAS号246543-32-8 2(1H)-PYRIDINON... | CAS号7440-44-0 活性炭 | CAS号1072-97-5 2-氨基-5-溴吡啶 | CAS号105544-30-7 2-(5-溴-3-硝基-2-吡... | CAS号1083326-05-9 N-(5-溴-2-甲氧基-3-... | CAS号1086063-46-8 N-(5-Bromo-2-me... | CAS号1083326-17-3 N-(5-溴-2-氯吡啶-3-... | CAS号37805-78-0 6-溴-3-甲基-3H-咪唑并... | CAS号505052-64-2 4-(5-溴-3-硝基吡啶-2-基)吗啉 | CAS号914358-73-9 2-甲基-3-氨基-5-溴吡啶 | CAS号425380-38-7 4-溴-7-氯-1H-吡咯并[... | CAS号944937-53-5 6-溴-4-氮杂吲哚 | CAS号446284-40-8 5-溴-3-硝基-2-(1H-...

5-溴-3-硝基-2(1H)-吡啶酮氢溴酸盐(1:1)置于五氯化磷,三氯氧磷体系中,用53.5%的收率获得产物5-溴-2-氯-3-硝基吡啶
参考文献:Antithrombotic Quinoxazolines
标题:Antithrombotic Quinoxazolines
摘要:奎诺沙唑啉具有抗血栓活性.其中一些示例包括:4-〔6-(N-羧甲基喹啉-8-基磺胺基)-1-甲基-2-氧代-1,2-二氢喹啉-3-基〕-甲基-苯甲酰胺,4-〔6-(1-(N-环戊基-羧甲基羰基氨基)-环丙基)-1-甲基-2-氧代-1,2-二氢喹啉-3-基〕-甲基-苯甲酰胺,以及4-〔7-(N-羧甲基氨基甲酰基乙基氨基)-4-甲基喹啉-2-基〕-氧代-苯甲酰胺.

专利信息

专利号:US-9573939-B2
优先权日:2011-09-08
标题:Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases
发明人：MCCOMAS CASEY C; LIVERTON NIGEL J; HABERMANN JOERG; KOCH UWE; NARJES FRANK; LI PENG; PENG XUANJIA; SOLL RICHARD; WU HAO; PALANI ANANDAN; DAI XING; LIU HONG; HE SHUWEN; DANG QUN
权利人:MCCOMAS CASEY C; LIVERTON NIGEL J; HABERMANN JOERG; KOCH UWE; NARJES FRANK; LI PENG; PENG XUANJIA; SOLL RICHARD; WU HAO; PALANI ANANDAN; DAI XING; LIU HONG; HE SHUWEN; DANG QUN; MERCK SHARP & DOHME; MSD ITALIA SRL
摘要:The present invention relates to compounds of formula (I) that are useful as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system.

专利号:US-8404670-B2
优先权日:2009-02-11
标题:Histamine H3 inverse agonists and antagonists and methods of use thereof
发明人：CHYTIL MILAN; ENGEL SHARON R; FANG QUN KEVIN; SPEAR KERRY L
权利人:CHYTIL MILAN; ENGEL SHARON R; FANG QUN KEVIN; SPEAR KERRY L; SUNOVION PHARMACEUTICALS INC
摘要:Provided herein are fused imidazolyl compounds, methods of synthesis, and methods of use thereof. The compounds provided herein are useful for the treatment, prevention, and/or management of various disorders, such as neurological disorders and metabolic disorders. Compounds provided herein inhibit the activity of histamine H3 receptors and modulate the release of various neurotransmitters, such as histamine, acetylcholine, norepinephrine, and dopamine (e.g. at the synapse). Pharmaceutical formulations containing the compounds and their methods of use are also provided herein.

专利号:US-6017926-A
优先权日:1997-12-17
标题 :Integrin receptor antagonists
发明人：ASKEW BEN C; COLEMAN PAUL J; DUGGAN MARK E; HALCZENKO WASYL; HUTCHINSON JOHN H; MEISSNER ROBERT S; PATANE MICHAEL A; WANG JIABING
权利人:MERCK & CO INC
摘要:The present invention relates to compounds and derivatives thereof, their synthesis, and their use as integrin receptor antagonists. More particularly, the compounds of the present invention are antagonists of the integrin receptors alpha v beta 3, alpha v beta 5 and/or alpha v beta 6 and are useful for inhibiting bone resorption, treating and preventing osteoporosis, and inhibiting vascular restenosis, diabetic retinopathy, macular degeneration, angiogenesis, atherosclerosis, inflammation, wound healing, viral disease, and tumor growth and metastasis.

专利号:US-2012329826-A1
优先权日:2010-03-03
标 题:Substituted-5-aminopyrrolo/pyrazolopyridines
发明人：LI AN-HU; GUPTA RAMESH C; MULVIHILL MARK J; RAI ANAND NARAIN; WANG JING
权利人:LI AN-HU; GUPTA RAMESH C; MULVIHILL MARK J; RAI ANAND NARAIN; WANG JING; OSI PHARMACEUTICALS LLC
摘要:Compounds of Formula I, as shown below and defined herein: pharmaceutically acceptable salts, synthesis, intermediates, formulations, and methods of disease treatment therewith, including cancers mediated at least in part by RON and/or MET.

专利号:EP-1040111-B1
优先权日:1997-12-17
标 题:Integrin receptor antagonists
发明人：DUGGAN MARK E; MEISSNER ROBERT S; HUTCHINSON JOHN H; HALCZENKO WASYL; ASKEW BEN C; COLEMAN PAUL J; PATANE MICHAEL A; WANG JIABING; PERKINS JAMES J
权利人:MERCK & CO INC
摘要:The present invention relates to compounds and derivatives thereof, their synthesis, and their use as integrin receptor antagonists. More particularly, the compounds of the present invention are antagonists of the integrin receptors alpha v beta 3, alpha v beta 5 and/or alpha v beta 6 and are useful for inhibiting bone resorption, treating and preventing osteoporosis, and inhibiting vascular restenosis, diabetic retinopathy, macular degeneration, angiogenesis, atherosclerosis, inflammation, wound healing, viral disease, and tumor growth and metastasis.

专利号:US-6268378-B1
优先权日:1997-12-17
标题 :Integrin receptor antagonists
发明人：DUGGAN MARK E; MEISSNER ROBERT S; PERKINS JAMES J
权利人:MERCK & CO INC
摘要:The present invention relates to compounds and derivatives thereof, their synthesis, and their use as vitronectin receptor antagonists. More particularly, the compounds of the present invention are antagonists of the vitronectin receptors alphavbeta3 and/or alphavbeta5 and are useful for inhibiting bone resorption, treating and preventing osteoporosis, and inhibiting vascular restenosis, diabetic retinopathy, macular degeneration, angiogenesis, atherosclerosis, inflammation, viral disease, and tumor growth.